Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1750
+0.0050 (2.86%)
Aug 1, 2025, 3:53 PM EDT
Verve Therapeutics Market Cap
Marvel Biosciences has a market cap or net worth of CAD 10.69 million as of August 1, 2025. Its market cap has increased by 123.97% in one year.
Market Cap
10.69M
Enterprise Value
12.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 10.69M, a decrease of -15.86%. That is a compound annual growth rate of -4.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 10.69M | 40.45% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | 12.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 1.89B |
| Sienna Senior Living | 1.65B |
| dentalcorp Holdings | 1.60B |
| Curaleaf Holdings | 1.44B |
| WELL Health Technologies | 1.16B |
| Trulieve Cannabis | 1.15B |
| Cronos Group | 1.06B |
| Extendicare | 1.03B |